Atypical oral candidiasis in a psoriatic patient during targeted immunotherapy with an interleukin 17 inhibitor (secukinumab)
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Atypical oral candidiasis in a psoriatic patient during targeted immunotherapy with an interleukin 17 inhibitor (secukinumab)
Authors
Keywords
-
Journal
BMC Oral Health
Volume 21, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-06-08
DOI
10.1186/s12903-021-01653-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Concurrent chronic hyperplastic candidosis and oral lichenoid lesion as adverse events of secukinumab therapy
- (2021) CS Farah AUSTRALIAN DENTAL JOURNAL
- Characterization of oral candidiasis and the Candida species profile in patients with oral mucosal diseases
- (2019) Lijun Hu et al. MICROBIAL PATHOGENESIS
- Effect of Probiotics on Oral Candidiasis: A Systematic Review and Meta-Analysis
- (2019) Tiziana Mundula et al. Nutrients
- Evaluation of an innovative oral brush for potential applications using liquid based cytology
- (2018) Omar Kujan et al. Journal of Oral Science
- Candida infections in psoriatic patients on anti-IL17 therapy: a case series
- (2018) Manuela Papini et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Efficacy and safety of brodalumab in patients with generalized pustular psoriasis and psoriatic erythroderma: results from a 52-week, open-label study
- (2016) K. Yamasaki et al. BRITISH JOURNAL OF DERMATOLOGY
- New therapies for psoriasis and psoriatic arthritis
- (2016) Christopher T. Ritchlin et al. CURRENT OPINION IN RHEUMATOLOGY
- Brodalumab, a human anti-interleukin-17-receptor antibody in the treatment of Japanese patients with moderate-to-severe plaque psoriasis: Efficacy and safety results from a phase II randomized controlled study
- (2016) Hidemi Nakagawa et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Oral lichen planus associated with candidiasis during secukinumab treatment
- (2016) Takaya Komori et al. JOURNAL OF DERMATOLOGY
- Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis
- (2016) Kenneth B. Gordon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Secukinumab in psoriasis: randomized, controlled phase 3 trial results assessing the potential to improve treatment response in partial responders (STATURE)
- (2015) D. Thaçi et al. BRITISH JOURNAL OF DERMATOLOGY
- IL-17–Mediated Immunity to the Opportunistic Fungal PathogenCandida albicans
- (2015) Heather R. Conti et al. JOURNAL OF IMMUNOLOGY
- Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2015) Iain B McInnes et al. LANCET
- Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis
- (2015) Philip J. Mease et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral lichen planus: An update on etiology, pathogenesis, clinical presentation, diagnosis and management
- (2015) Sonia Gupta et al. INDIAN JOURNAL OF DERMATOLOGY
- Secukinumab administration by pre-filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE)
- (2014) A. Blauvelt et al. BRITISH JOURNAL OF DERMATOLOGY
- Safety and efficacy of brodalumab for psoriasis after 120 weeks of treatment
- (2014) Kim Papp et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
- (2014) Richard G. Langley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral candidiasis in patients with psoriasis: Correlation of oral examination and cytopathological evaluation with psoriasis disease severity and treatment
- (2013) Bruna Lavinas Sayed Picciani et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Immunity to infection in IL-17-deficient mice and humans
- (2012) Sophie Cypowyj et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis
- (2009) Heather R. Conti et al. JOURNAL OF EXPERIMENTAL MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More